300015 爱尔眼科
已收盘 09-09 15:00:00
资讯
新帖
简况
爱尔眼科：公司通过现金分红、股份回购并拟注销等多种方式传递对未来的信心
证券之星 · 09-08 20:51
爱尔眼科：公司通过现金分红、股份回购并拟注销等多种方式传递对未来的信心
爱尔眼科：UBS、Wu Advisors Pte Ltd等多家机构于9月4日调研我司
证券之星 · 09-08 02:12
爱尔眼科：UBS、Wu Advisors Pte Ltd等多家机构于9月4日调研我司
爱尔眼科：上半年末公司股东总数为338,543户
证券之星 · 09-03
爱尔眼科：上半年末公司股东总数为338,543户
求真价值，智见未来｜证券之星“发现中国好公司”参访活动走进上海爱尔眼科
证券之星 · 08-28
求真价值，智见未来｜证券之星“发现中国好公司”参访活动走进上海爱尔眼科
爱尔眼科(300015)6月30日股东户数33.85万户，较上期减少1.64%
证券之星 · 08-28
爱尔眼科(300015)6月30日股东户数33.85万户，较上期减少1.64%
8月28日爱尔眼科发生1笔大宗交易 成交金额8476.84万元
证券之星 · 08-28
8月28日爱尔眼科发生1笔大宗交易 成交金额8476.84万元
爱尔眼科最新公告：上半年净利润13.57亿元同比下降33.83%
证券之星 · 08-27
爱尔眼科最新公告：上半年净利润13.57亿元同比下降33.83%
爱尔眼科上半年净利润同比下滑33.83%
投资观察 · 08-27
爱尔眼科上半年净利润同比下滑33.83%
爱尔眼科：专注主业，持续创新
证券之星 · 08-13
爱尔眼科：专注主业，持续创新
爱尔眼科：基金工商登记程序在办理过程中
证券之星 · 08-13
爱尔眼科：基金工商登记程序在办理过程中
爱尔眼科：公司作为有限合伙人仅履行出资义务
证券之星 · 08-12
爱尔眼科：公司作为有限合伙人仅履行出资义务
爱尔眼科（300015）披露完成市场主体变更登记公告，8月10日股价上涨2.83%
证券之星 · 08-10
爱尔眼科（300015）披露完成市场主体变更登记公告，8月10日股价上涨2.83%
爱尔眼科：公司作为有限合伙人出资设立产业专项基金
证券之星 · 08-07
爱尔眼科：公司作为有限合伙人出资设立产业专项基金
爱尔眼科：公司专注眼科医疗，持续关注多学科交叉前沿领域发展
证券之星 · 08-04
爱尔眼科：公司专注眼科医疗，持续关注多学科交叉前沿领域发展
爱尔眼科：老花与干眼业务目前基数不高但未来潜力巨大
证券之星 · 08-04
爱尔眼科：老花与干眼业务目前基数不高但未来潜力巨大
爱尔眼科：全光塑、全飞秒PRO、ICL V5等先进技术术式占比稳步提升
证券之星 · 08-04
爱尔眼科：全光塑、全飞秒PRO、ICL V5等先进技术术式占比稳步提升
爱尔眼科：优化组织结构和管理流程
证券之星 · 08-04
爱尔眼科：优化组织结构和管理流程
爱尔眼科（300015）披露实际控制人部分股份质押及解除质押公告，8月3日股价下跌0.22%
证券之星 · 08-03
爱尔眼科（300015）披露实际控制人部分股份质押及解除质押公告，8月3日股价下跌0.22%
股市必读：爱尔眼科新发布《关于与专业投资机构共同投资专项基金的公告》
证券之星 · 08-03
股市必读：爱尔眼科新发布《关于与专业投资机构共同投资专项基金的公告》
巴维埃拉上半年净利润达2670万欧元
投资观察 · 07-29
巴维埃拉上半年净利润达2670万欧元
暂无数据
公司概况
公司名称：
爱尔眼科医院集团股份有限公司
所属行业：
卫生
上市日期：
2009-10-30
主营业务：
爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。
发行价格：
28.00
{"stockData":{"symbol":"300015","market":"SZ","secType":"STK","nameCN":"爱尔眼科","latestPrice":8.24,"timestamp":1788937437000,"preClose":8.35,"halted":0,"volume":38685036,"delay":0,"changeRate":-0.0132,"floatShares":7958000000,"shares":9300000000,"eps":0.2739,"marketStatus":"已收盘","change":-0.11,"latestTime":"09-09 15:00:00","open":8.35,"high":8.35,"low":8.22,"amount":320000000,"amplitude":0.0156,"askPrice":8.25,"askSize":820,"bidPrice":8.24,"bidSize":8156,"shortable":0,"etf":0,"ttmEps":0.2739,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789003800000},"marketStatusCode":5,"adr":0,"adjPreClose":8.35,"symbolType":"stock","openAndCloseTimeList":[[1788917400000,1788924600000],[1788930000000,1788937200000]],"highLimit":9.19,"lowLimit":7.52,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":9299564734,"isCdr":false,"pbRate":3.37,"roa":"--","peRate":30.083972,"roe":"6.04%","epsLYR":0.3496,"committee":0.681118,"marketValue":76628000000,"turnoverRate":0.0049,"status":1,"floatMarketCap":65573000000},"requestUrl":"/m/hq/s/300015/tweets","defaultTab":"tweets","newsList":[{"id":"2665373917","title":"爱尔眼科：公司通过现金分红、股份回购并拟注销等多种方式传递对未来的信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665373917?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:51","pubTimestamp":1788871868,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科09月07日在投资者关系平台上答复投资者关心的问题。公司通过现金分红、股份回购并拟注销等多种方式传递对未来的信心。虽然外部环境复杂多变，但居民眼健康的潜在需求持续增长，公司坚定看好未来，持续精进主业，提升内在价值。路遥知马力，日久见本真。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800034453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","LU1242518931.SGD","BK0236","BK0200","BK0077","LU0979878070.USD","LU1146622755.USD","BK0012","BK0096","BK0028","BK0113","BK0114","LU1820825898.SGD","BK0188","BK0196","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665310939","title":"爱尔眼科：UBS、Wu Advisors Pte Ltd等多家机构于9月4日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2665310939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665310939?lang=zh_cn&edition=full","pubTime":"2026-09-08 02:12","pubTimestamp":1788804739,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月7日爱尔眼科发布公告称UBS魏嘉瑞、Wu Advisors Pte LtdEe Leng Lau、UG Investment AdvisersLucia Fong于2026年9月4日调研我司。此前，成都爱尔已获评三甲眼科医院。实际上，中国眼科潜在需求持续增长，这在公司定期报告中均有深入的分析，绝大多数眼病的病理特性决定了需求只可能推迟，不可能消失。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800000651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0077","BK0114","BK0200","LU1820825898.SGD","LU1146622755.USD","BK0236","LU1242518857.USD","BK0196","BK0012","BK0188","LU0979878070.USD","LU1242518931.SGD","BK0096","300015","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664282479","title":"爱尔眼科：上半年末公司股东总数为338,543户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664282479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664282479?lang=zh_cn&edition=full","pubTime":"2026-09-03 15:18","pubTimestamp":1788419900,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)09月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，贵公司截止2026年8月28日公司股东人数为多少？爱尔眼科回复：谢谢关注。公司按照有关法规履行信息披露义务，上半年末公司股东总数为338,543户。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300022802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0979878070.USD","300015","LU1146622755.USD","LU1242518931.SGD","LU1820825898.SGD","BK0200","BK0012","BK0236","BK0096","BK0028","BK0196","LU1242518857.USD","BK0114","BK0113","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662268095","title":"求真价值，智见未来｜证券之星“发现中国好公司”参访活动走进上海爱尔眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2662268095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662268095?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:23","pubTimestamp":1787923407,"startTime":"0","endTime":"0","summary":"2026年8月28日，由证券之星主办的“发现中国好公司”走进上市公司系列调研活动落地上海爱尔眼科医院。证券之星“发现中国好公司”系列走进上市公司活动，致力于打通上市公司、机构投资者与产业界的沟通通路，以实地走访的形式，帮助市场求真企业内在价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026082800052478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0012","BK0028","LU0979878070.USD","LU1242518931.SGD","BK0096","LU1146622755.USD","BK0200","BK0188","BK0196","300015","BK0114","BK0236","BK0113","LU1820825898.SGD","161027","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066258","title":"爱尔眼科(300015)6月30日股东户数33.85万户，较上期减少1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066258","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662066258?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:51","pubTimestamp":1787910665,"startTime":"0","endTime":"0","summary":"证券之星消息，近日爱尔眼科披露，截至2026年6月30日公司股东户数为33.85万户，较3月31日减少5653.0户，减幅为1.64%。在医疗服务行业个股中，爱尔眼科股东户数高于行业平均水平，截至6月30日，医疗服务行业平均股东户数为4.76万户。从股价来看，2026年3月31日至2026年6月30日，爱尔眼科区间跌幅为13.14%，在此期间股东户数减少5653.0户，减幅为1.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800041389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0200","BK0196","BK0012","BK0096","BK0028","BK0077","BK0236","LU0979878070.USD","LU1820825898.SGD","300015","BK0188","LU1146622755.USD","BK0114","LU1242518931.SGD","BK0113","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662065937","title":"8月28日爱尔眼科发生1笔大宗交易 成交金额8476.84万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662065937?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:32","pubTimestamp":1787909569,"startTime":"0","endTime":"0","summary":"证券之星消息，8月28日爱尔眼科发生大宗交易，交易数据如下：大宗交易成交价格8.31元，相对当日收盘价溢价0.73%，成交1020.08万股，成交金额8476.84万元，买方营业部为机构专用，卖方营业部为机构专用。近三个月该股共发生5笔大宗交易，合计成交31.34万手，折价成交2笔，溢价成交2笔。该股在过去半年内已有共计0.0股限售解禁股上市，占公司总股本的0.0%。截至2026年8月28日收盘，爱尔眼科报收于8.25元，下跌3.17%，换手率1.53%，成交量122.11万手，成交额10.14亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","LU0979878070.USD","LU1242518857.USD","BK0188","BK0196","BK0236","BK0028","300015","BK0114","BK0113","LU1242518931.SGD","BK0077","BK0200","LU1820825898.SGD","BK0096","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662693704","title":"爱尔眼科最新公告：上半年净利润13.57亿元同比下降33.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662693704","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662693704?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:32","pubTimestamp":1787830379,"startTime":"0","endTime":"0","summary":"爱尔眼科(300015.SZ)公告称，公司发布2026年半年度报告，实现营业收入119.46亿元，同比增长3.81%；归属于上市公司股东的净利润13.57亿元，同比下降33.83%。注：公司Q2净利润1.76亿，Q1净利润11.81亿，据此计算，Q2净利润环比下降85%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700046306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158289552","title":"爱尔眼科上半年净利润同比下滑33.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158289552","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158289552?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:19","pubTimestamp":1787829599,"startTime":"0","endTime":"0","summary":"8月27日，路透社消息——爱尔眼科医院集团股份有限公司（股票代码：300015.SZ）披露了其上半年财务表现。数据显示，该公司期内净利润较去年同期大幅缩减，降幅达到33.83%。\n这一业绩变动反映出眼科医疗行业在当前市场环境下面临的挑战。尽管具体影响因素尚未详细披露，但利润下滑的幅度已引起投资者关注。\n值得注意的是，这一数据基于公司发布的初步财务信息，后续完整财报或提供更多细节。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","LU1820825898.SGD","BK0012","BK0114","BK0077","LU1146622755.USD","300015","BK0196","LU0979878070.USD","LU1242518857.USD","BK0200","LU1242518931.SGD","BK0188","BK0028","BK0113","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659137215","title":"爱尔眼科：专注主业，持续创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2659137215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659137215?lang=zh_cn&edition=full","pubTime":"2026-08-13 17:00","pubTimestamp":1786611646,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)08月13日在投资者关系平台上答复投资者关心的问题。投资者提问：科技兴起，公司会投资芯片类？如眼镜，或医疗治疗类芯片？爱尔眼科回复：谢谢关注。公司专注主业，持续创新，为全年龄段人群提供高质量、多层次的眼科诊疗服务。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300027458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518931.SGD","LU1820825898.SGD","BK0012","LU1146622755.USD","BK0188","BK0113","LU1242518857.USD","BK0028","BK0114","BK0077","BK0236","300015","LU0979878070.USD","BK0196","BK0096","BK0200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659187076","title":"爱尔眼科：基金工商登记程序在办理过程中","url":"https://stock-news.laohu8.com/highlight/detail?id=2659187076","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659187076?lang=zh_cn&edition=full","pubTime":"2026-08-13 11:33","pubTimestamp":1786591987,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)08月13日在投资者关系平台上答复投资者关心的问题。投资者提问：公司董秘在8月份回复了关于公司认购共青城盛启的合伙份额事项，回复内容答非所问，代表投资者再次提问：1、共青城盛启具体投资企业是什么？市场传言说是Kimi，准确吗？2、为何到现在共青城盛启工商登记还没有公司呢。爱尔眼科回复：谢谢关注。公司按照相关规则进行信息披露，基金工商登记程序在办理过程中。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300015239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","LU1820825898.SGD","BK0012","BK0114","BK0077","LU1146622755.USD","300015","BK0196","LU0979878070.USD","LU1242518857.USD","BK0200","LU1242518931.SGD","BK0188","BK0028","BK0113","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658275749","title":"爱尔眼科：公司作为有限合伙人仅履行出资义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2658275749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658275749?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:00","pubTimestamp":1786521651,"startTime":"0","endTime":"0","summary":"公司作为有限合伙人，仅履行出资义务，不参与基金日常投资决策，该基金的最终投资标的属于基金独立决策范畴。相关信息以公司已披露的公告及基金自身向工商登记机关办理的注册信息为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200024772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0200","BK0113","LU1242518931.SGD","LU0979878070.USD","LU1146622755.USD","LU1820825898.SGD","BK0028","BK0188","BK0236","BK0114","BK0077","BK0196","LU1242518857.USD","BK0012","300015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658934718","title":"爱尔眼科（300015）披露完成市场主体变更登记公告，8月10日股价上涨2.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658934718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658934718?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:02","pubTimestamp":1786370553,"startTime":"0","endTime":"0","summary":"公司于近日披露《关于完成市场主体变更登记的公告》。公告显示，爱尔眼科医院集团股份有限公司于2026年4月23日召开第七届董事会第五次会议，2026年5月18日召开2025年年度股东会，审议通过关于回购注销2021年限制性股票激励计划部分限制性股票、变更注册资本、修订《公司章程》及办理市场主体变更登记的议案。公司已于2026年7月8日完成限制性股票回购注销手续，注册资本由9,325,396,670元变更为9,299,564,734元，股份总数相应变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000033530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0113","LU0979878070.USD","BK0096","LU1242518857.USD","BK0077","300015","BK0188","BK0012","BK0200","LU1146622755.USD","BK0114","LU1242518931.SGD","BK0196","LU1820825898.SGD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657662232","title":"爱尔眼科：公司作为有限合伙人出资设立产业专项基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2657662232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657662232?lang=zh_cn&edition=full","pubTime":"2026-08-07 08:40","pubTimestamp":1786063222,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科08月07日在投资者关系平台上答复投资者关心的问题。公司作为有限合伙人出资设立产业专项基金，仅承担有限出资风险，不参与基金投资决策，符合相关规则要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700007997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","BK0012","LU0979878070.USD","LU1242518857.USD","BK0200","BK0196","LU1242518931.SGD","BK0188","BK0077","BK0028","BK0096","BK0114","LU1820825898.SGD","BK0236","BK0113","300015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656208538","title":"爱尔眼科：公司专注眼科医疗，持续关注多学科交叉前沿领域发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2656208538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656208538?lang=zh_cn&edition=full","pubTime":"2026-08-04 15:18","pubTimestamp":1785827901,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司作为专业眼科头部企业，现在最前沿的通过脑机接口帮助视力残障人士重现光明的人脑工程研发居然没有任何介入？爱尔眼科回复：谢谢关注。公司专注眼科医疗，持续关注多学科交叉前沿领域发展。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400020178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK0200","BK0196","BK0012","BK0077","BK0114","300015","BK0236","BK0113","LU0979878070.USD","LU1146622755.USD","BK0096","LU1242518857.USD","LU1242518931.SGD","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656758538","title":"爱尔眼科：老花与干眼业务目前基数不高但未来潜力巨大","url":"https://stock-news.laohu8.com/highlight/detail?id=2656758538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656758538?lang=zh_cn&edition=full","pubTime":"2026-08-04 15:15","pubTimestamp":1785827724,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科08月04日在投资者关系平台上答复投资者关心的问题。随着国民眼健康意识逐步提升，潜在眼科医疗需求持续转化为现实有效需求，总体来说，相对于巨大的患者数量，老花与干眼业务目前基数不高，但未来潜力巨大，公司在各地医院持续科普患教并提供多种综合治疗方式，力求标本兼治、长治久安，为患者提供满意的医疗效果。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400020162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","BK0096","BK0200","BK0113","BK0236","LU0979878070.USD","BK0028","LU1242518931.SGD","BK0114","300015","LU1820825898.SGD","LU1242518857.USD","BK0012","BK0188","BK0196","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656538205","title":"爱尔眼科：全光塑、全飞秒PRO、ICL V5等先进技术术式占比稳步提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2656538205","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656538205?lang=zh_cn&edition=full","pubTime":"2026-08-04 15:15","pubTimestamp":1785827724,"startTime":"0","endTime":"0","summary":"公司以患者为中心，坚持“适合的才是最好的”，满足患者的多层次、个性化需求，屈光术式丰富完整，其中全光塑、全飞秒PRO、ICL V5等先进技术、术式占比稳步提升，充分体现了患者追求效果优先的基本特点，与一般消费大众追求“性价比”有所不同。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400020161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","LU1146622755.USD","BK0096","LU1242518931.SGD","BK0028","BK0188","BK0113","LU1242518857.USD","LU1820825898.SGD","BK0114","BK0196","BK0012","BK0236","300015","LU0979878070.USD","BK0200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656953842","title":"爱尔眼科：优化组织结构和管理流程","url":"https://stock-news.laohu8.com/highlight/detail?id=2656953842","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656953842?lang=zh_cn&edition=full","pubTime":"2026-08-04 15:12","pubTimestamp":1785827543,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科08月04日在投资者关系平台上答复投资者关心的问题。公司因势而变、因地制宜，根据各省区、医院的具体情况，打破行政区划和职能壁垒，优化组织结构、管理流程，通过区县一体化、同城一体化，实现以快带慢、以强带弱。通过管理模式的动态优化、数字化管理的推广，以及系列降本增效举措的落地，推动资源整合共享，促进管理效率的提升和各连锁医院医疗服务同质化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400020144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","LU1242518857.USD","300015","LU0979878070.USD","BK0200","LU1146622755.USD","BK0012","BK0236","BK0028","LU1820825898.SGD","BK0114","BK0188","BK0113","LU1242518931.SGD","BK0077","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656453327","title":"爱尔眼科（300015）披露实际控制人部分股份质押及解除质押公告，8月3日股价下跌0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656453327","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656453327?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:46","pubTimestamp":1785750372,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，爱尔眼科报收于9.06元，较前一交易日下跌0.22%，最新总市值为842.54亿元。近日，爱尔眼科医院集团股份有限公司发布公告，公司实际控制人陈邦先生将其持有的公司部分股份办理了质押及解除质押业务。本次合计质押股份160,000,000股，占其所持股份比例11.08%，占公司总股本比例1.72%，质押用途为偿还借款，质权人为华泰证券（上海）资产管理有限公司。同时，陈邦先生解除质押股份139,000,000股，占其所持股份比例9.63%，占公司总股本比例1.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300024184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","LU1146622755.USD","LU0979878070.USD","BK0188","BK0236","LU1242518857.USD","BK0096","BK0077","BK0114","BK0113","BK0200","300015","LU1820825898.SGD","LU1242518931.SGD","BK0196","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656207348","title":"股市必读：爱尔眼科新发布《关于与专业投资机构共同投资专项基金的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656207348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656207348?lang=zh_cn&edition=full","pubTime":"2026-08-03 01:53","pubTimestamp":1785693189,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，爱尔眼科报收于9.08元，上涨0.0%，换手率1.03%，成交量82.2万手，成交额7.42亿元。公司公告汇总关于与专业投资机构共同投资专项基金的公告爱尔眼科以自有资金20,000万元人民币参与投资共青城坚持盛启创业投资合伙企业，该基金认缴出资总额为70,210万元，专项投资于单一标的股权。本次投资无需提交董事会及股东会审议。本次变动后，陈邦累计质押股份占其所持股份比例为19.53%。如有相关计划，公司将及时披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300000733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","BK0188","BK0114","BK0196","BK0096","BK0236","BK0012","300015","BK0028","BK0077","BK0113","LU0979878070.USD","LU1820825898.SGD","BK0200","LU1242518931.SGD","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108381075","title":"巴维埃拉上半年净利润达2670万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108381075","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108381075?lang=zh_cn&edition=full","pubTime":"2026-07-29 23:51","pubTimestamp":1785340319,"startTime":"0","endTime":"0","summary":"7月29日，Clinica Baviera SA公布上半年财务业绩。数据显示，公司上半年营收达1.699亿欧元，净利润为2670万欧元，EBITDA录得5060万欧元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0200","LU1242518857.USD","300015","BK0113","BK0012","BK0114","BK0188","BK0196","LU1146622755.USD","LU1242518931.SGD","BK0096","LU0979878070.USD","BK0236","LU1820825898.SGD","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788978151113,"stockEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":-0.0915},{"period":"3month","weight":-0.0093},{"period":"6month","weight":-0.1799},{"period":"1year","weight":-0.3482},{"period":"ytd","weight":-0.236}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0038},{"period":"3month","weight":-0.0089},{"period":"6month","weight":-0.0351},{"period":"1year","weight":0.0379},{"period":"ytd","weight":-0.0044}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱尔眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"338543人(较上一季度减少1.64%)","perCapita":"23506股","listingDate":"2009-10-30","address":"湖南省长沙市天心区芙蓉南路一段188号爱尔大厦","registeredCapital":"929956万元","survey":" 爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔眼科,300015,爱尔眼科股票,爱尔眼科股票老虎,爱尔眼科股票老虎国际,爱尔眼科行情,爱尔眼科股票行情,爱尔眼科股价,爱尔眼科股市,爱尔眼科股票价格,爱尔眼科股票交易,爱尔眼科股票购买,爱尔眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}